Alpha Peptide Research Labs
Alpha Peptide ResearchLabs
Cognitive & Mood SupportApproved Internationally

Selank

Selank (Synthetic Tuftsin Analog)

A non-sedating anti-anxiety peptide that calms your mind while sharpening your focus, offering benzodiazepine-level relief without the downsides.

5 studies referencedAnxiety & Focus

Selank is a synthetic peptide based on tuftsin, a molecule your immune system naturally produces. It was developed by the Institute of Molecular Genetics at the Russian Academy of Sciences as a safer alternative to benzodiazepines like Xanax and Valium for treating anxiety. What sets Selank apart from traditional anti-anxiety medications is that it reduces anxiety without making you drowsy, impairing your thinking, or creating any risk of dependence. It has been an approved prescription medication in Russia since the early 2000s, where doctors use it for generalized anxiety disorder, neurasthenia, and stress-related conditions. In the United States, it remains a research compound without FDA approval.

What makes Selank genuinely unusual is that it works through multiple pathways at once. It enhances GABA (your brain's main calming chemical), influences serotonin and dopamine (which affect mood and motivation), supports immune function, and increases BDNF (a protein that helps your brain form new connections). This gives it a rare triple profile: it fights anxiety, boosts cognitive performance, and supports your immune system all at the same time. Most anti-anxiety drugs impair your thinking, but Selank does the opposite.

For people dealing with chronic stress, anxiety, or mental fatigue, Selank represents a fundamentally different approach than stimulants or traditional pharmaceuticals. It calms without sedating and sharpens focus without causing jitteriness, making it something you can use during the day while still performing at your best.

How It Works

Think of GABA as your brain's braking system. When things get too hectic up there, GABA steps in and slows neuronal activity down, creating a sense of calm. This is the same system that drugs like Xanax target. The problem with those drugs is that they slam on the brakes too hard, which is why they make you drowsy and foggy. Selank takes a gentler approach. Instead of directly activating the GABA receptor the way benzodiazepines do, it acts as what scientists call a 'positive allosteric modulator.' In plain language, it changes the shape of the GABA receptor so that your brain's own GABA can bind to it more effectively. The result is stronger calming signals without the heavy-handed sedation that comes from forcing the receptor open directly.

Beyond the calming effects, Selank also boosts BDNF (brain-derived neurotrophic factor) in areas of the brain responsible for memory and learning. BDNF is like fertilizer for your brain cells: it helps them grow new connections, strengthen existing ones, and stay healthy. Selank also fine-tunes your serotonin metabolism (which stabilizes mood), regulates dopamine and norepinephrine (which support focus and motivation), and influences enkephalin activity (natural chemicals that help manage pain and stress). It even retains immune-boosting properties from its parent molecule, tuftsin.

This multi-pathway action is the key to understanding why Selank can reduce anxiety while simultaneously improving cognitive performance. In clinical studies, patients receiving Selank showed anxiety reductions comparable to benzodiazepines, but they also experienced improved energy and mental sharpness rather than impairment. The anti-anxiety effects have been shown to persist for up to a week after stopping the peptide, which suggests Selank helps retrain your stress response system rather than just masking symptoms temporarily.

Potential Benefits

Anxiety Reduction Without Sedation

The primary benefit of Selank is anxiety relief that does not compromise your ability to function. In clinical trials comparing it to benzodiazepines, Selank produced equivalent anxiety reduction without any sedative effects. You can use it during the day without feeling drowsy, foggy, or mentally impaired, which is a major advantage over conventional anti-anxiety medications.

Cognitive Enhancement

Selank functions as a nootropic, meaning it improves memory, attention, and information processing. By increasing BDNF, it supports synaptic plasticity, which is the foundation of learning and memory. Users commonly report improved focus and mental clarity, especially in stressful situations where cognitive performance typically suffers.

Stress Resilience

Rather than just suppressing anxiety symptoms, Selank helps regulate your HPA axis (the system that controls your stress response). With continued use, people report feeling more resilient and less reactive to daily stressors. This is a fundamental shift in how your body handles stress, not just a band-aid.

No Dependence or Withdrawal

Unlike benzodiazepines, which can create physical dependence within weeks and cause dangerous withdrawal symptoms, Selank does not cause dependence or withdrawal at all. You can use it as needed or in cycles without worrying about becoming reliant on it to function normally.

Immune System Support

Selank retains immunomodulatory properties from its parent molecule tuftsin. Research shows it can influence cytokine expression and may have antiviral properties. This is especially relevant for people dealing with chronic stress, which typically weakens immune function over time.

What the Research Shows

Approved Internationally

Selank has more human clinical data than most research peptides, primarily from Russian studies. In a study by Zozulia and colleagues (2008) published in the Journal of Neurology and Psychiatry, 62 patients with generalized anxiety disorder and neurasthenia were treated with either Selank or medazepam (a benzodiazepine). Both groups showed similar reductions in anxiety on the Hamilton and Zung scales, which are the gold-standard measurements for anxiety severity. However, the Selank group also experienced energy-boosting and mentally stimulating effects that the benzodiazepine group did not, making Selank effective for the fatigue that often accompanies chronic anxiety.

A 2014 comparative study by Seredenin and colleagues tested Selank against phenazepam (another benzodiazepine) in 60 patients with anxiety disorders. Selank produced clear anxiolytic effects along with mild cognitive enhancement. One of the most striking findings was that the anti-anxiety effect lasted for a full week after the last dose, suggesting lasting changes rather than temporary symptom suppression. Selank also improved quality-of-life scores without the cognitive side effects that plagued the phenazepam group.

At the molecular level, a 2017 study by Filatova and colleagues published in Frontiers in Pharmacology found that Selank administration altered the expression of 45 genes involved in brain signaling within just one hour. These gene-expression changes closely mirrored those produced by GABA itself, providing strong evidence that Selank works through the GABAergic system. Additionally, radioligand binding studies by Kasian and colleagues (2019) confirmed that Selank acts as a positive allosteric modulator of GABA receptors, competing with diazepam for binding sites but producing different, gentler effects.

What to Know

CommonImportantSerious

Mild nasal irritation may occur with intranasal use, which is the most frequently reported side effect and is generally transient.

Occasional mild headache has been reported, though it tends to resolve on its own without intervention.

Some users experience mild fatigue, though this is uncommon and clinical studies specifically noted the absence of sedation.

Should not be combined with benzodiazepines or other GABAergic medications due to potential additive effects on the calming system. Use caution with SSRIs or SNRIs since Selank also modulates serotonin.

People with autoimmune conditions should use caution due to Selank's immunomodulatory effects, and those with a history of allergic reactions to peptides should avoid use entirely.

Effects on pregnancy and breastfeeding are unknown and have not been studied; use should be avoided entirely in these populations.

Research References

  1. Efficacy and possible mechanisms of action of a new peptide anxiolytic Selank in the therapy of generalized anxiety disorders and neurasthenia

    Zozulia AA, Neznamov GG, Siuniakov TS, et al. · Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova · 2008

    Compared Selank to medazepam in 62 patients with GAD and neurasthenia; both showed similar anxiety reductions on Hamilton and Zung scales, but Selank also produced energy-boosting and psychostimulant effects absent in the benzodiazepine group.

    View Study
  2. A comparison of the anxiolytic effect and tolerability of Selank and phenazepam in the treatment of anxiety disorders

    Seredenin SB, Kozlovskaia MM, et al. · Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova · 2014

    Compared Selank to phenazepam in 60 anxiety disorder patients; Selank produced pronounced anxiolytic and mild nootropic effects, with anti-anxiety benefits lasting a week after the last dose and improved quality of life without cognitive side effects.

    View Study
  3. GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells

    Filatova E, Kasian A, Kolomin T, et al. · Frontiers in Pharmacology · 2017

    Found that Selank altered expression of 45 genes involved in neurotransmission within one hour, with changes positively correlated with those produced by GABA itself, supporting the GABAergic mechanism of action.

    View Study
  4. Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats

    Kasian A, Kolomin T, Andreeva L, et al. · Behavioural Neurology · 2017

    Radioligand binding studies showed Selank acts as a positive allosteric modulator of GABA receptors, competing with diazepam for binding sites but producing distinct effects through a related but different site on the receptor complex.

    View Study
  5. Antiviral activity of immunomodulator Selank in experimental influenza infection

    Ershov FI, et al. · Voprosy Virusologii · 2009

    Demonstrated Selank's antiviral properties in experimental influenza models, supporting the immunomodulatory benefits retained from its parent molecule tuftsin.

    View Study

Related Peptides

For Research Use Only

This content is for research and educational purposes only and does not constitute medical advice. Always consult your medical provider before making any health decisions. The information presented is based on published, peer-reviewed research and does not constitute an endorsement of any compound for human use.